Asarfi Hospital Ltd
ASARFI Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
3 of 4 strong
The short version
- Targeting revenue of INR 260 crores for FY27, up from INR 173.5 crores in FY26. - Asarfi Hospital targets revenue growth to INR 260 crores in FY27, with confidence in achieving this through bed expansions, increased patient flow, and service ramp-up.
From Asarfi Hospital Ltd's Q4 FY26 earnings-call transcript · updated 24 Jun 2026.
Revenue & Sales Performance
- Targeting revenue of INR 260 crores for FY27, up from INR 173.5 crores in FY26.
- Aim to scale overall bed capacity to over 500 beds by 2028 (from current 350 beds).
- Cancer hospital capacity to increase from 65 beds to 150 beds, with significant revenue growth expected from this segment.
- Revenue growth driven by bed expansion, occupancy ramp-up, ARPOB (Average Revenue Per Occupied Bed) improvement, transplant services, and management contracts.
- Expect organic and inorganic growth, including hospital acquisitions planned in FY27.
- Bone marrow transplant facility to start contributing revenue from FY28.
- Long-term plan targets INR 400 crores revenue and EBITDA margin of 23-25%.
2 more points from Asarfi Hospital Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Asarfi Hospital Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Healthcare Management Research Institute under construction with expected capex of INR 8 to 10 crores in the coming fiscal year.
- Additional capex of INR 2 to 3 crores planned to unlock current capacity and expand super specialty and oncology beds — total FY27 capex expected to be under INR 15 crores.
- Bed expansion plan to increase cancer hospital beds from 65 to 150, with relatively low capex of INR 2 to 3 crores due to existing infrastructure.
- Inorganic growth through hospital acquisition is underway, with technical issues being resolved and materialization expected within the financial year.
- Potential strategic management contracts and partnerships in nearby regions are in exploration as part of growth strategy.
2 more points from Asarfi Hospital Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Asarfi Hospital Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Asarfi Hospital Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Asarfi Hospital Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹45 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Asarfi Hospital's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Scie. (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnos. (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnos.'s Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Arthneeti Pro · Annual
Asarfi Hospital Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Asarfi Hospital Ltd Q1 FY27 results?
- Targeting revenue of INR 260 crores for FY27, up from INR 173.5 crores in FY26. - Asarfi Hospital targets revenue growth to INR 260 crores in FY27, with confidence in achieving this through bed expansions, increased patient flow, and service ramp-up.
What is Asarfi Hospital Ltd share price analysis?
Asarfi Hospital Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 29.6 with a market cap of ₹497. Investors should review the full earnings analysis for detailed insights.
Is Asarfi Hospital Ltd planning capital expenditure?
- Healthcare Management Research Institute under construction with expected capex of INR 8 to 10 crores in the coming fiscal year.
Keep Asarfi Hospital Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.